Thomas E Breen
First SEC filing: Nov. 9, 2016 · Latest: Feb. 26, 2018
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2018 | CPSH | A | 7,000 | $1.53 | $10,710 | 160,000 Direct | +4.58% | Acquired | 151.0% (price as of 2026-10-02) |
| Feb. 23, 2018 | CPSH | A | 7,000 | $1.53 | $10,710 | 153,000 Direct | +4.79% | Acquired | 151.0% (price as of 2026-10-02) |
| Feb. 23, 2018 | CPSH | A | 7,000 | $1.53 | $10,710 | 146,000 Direct | +5.04% | Acquired | 151.0% (price as of 2026-10-02) |
| Feb. 23, 2018 | CPSH | A | 7,000 | $1.53 | $10,710 | 139,000 Direct | +5.30% | Acquired | 151.0% (price as of 2026-10-02) |
| Feb. 23, 2018 | CPSH | A | 7,000 | $1.53 | $10,710 | 132,000 Direct | +5.60% | Acquired | 151.0% (price as of 2026-10-02) |
| Feb. 17, 2017 | CPSH | A | 5,000 | $1.57 | $7,850 | 125,000 Direct | +4.17% | Acquired | 144.6% (price as of 2026-10-02) |
| Feb. 17, 2017 | CPSH | A | 5,000 | $1.57 | $7,850 | 120,000 Direct | +4.35% | Acquired | 144.6% (price as of 2026-10-02) |
| Feb. 17, 2017 | CPSH | A | 5,000 | $1.57 | $7,850 | 115,000 Direct | +4.55% | Acquired | 144.6% (price as of 2026-10-02) |
| Feb. 17, 2017 | CPSH | A | 5,000 | $1.57 | $7,850 | 110,000 Direct | +4.76% | Acquired | 144.6% (price as of 2026-10-02) |
| Feb. 17, 2017 | CPSH | A | 5,000 | $1.57 | $7,850 | 105,000 Direct | +5.00% | Acquired | 144.6% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 23, 2018 | CPSH | Stock Options | Stock Options | $1.53 | Feb. 22, 2028 | 7,000 | Acquired |
| Feb. 23, 2018 | CPSH | Stock Options | Stock Options | $1.53 | Feb. 23, 2028 | 7,000 | Acquired |
| Feb. 23, 2018 | CPSH | Stock Options | Stock Options | $1.53 | Feb. 23, 2028 | 7,000 | Acquired |
| Feb. 23, 2018 | CPSH | Stock Options | Stock Options | $1.53 | Feb. 23, 2028 | 7,000 | Acquired |
| Feb. 23, 2018 | CPSH | Stock Options | Stock Options | $1.53 | Feb. 23, 2028 | 7,000 | Acquired |
| Feb. 17, 2017 | CPSH | Common Stock | Common Stock | $1.57 | Feb. 17, 2027 | 5,000 | Acquired |
| Feb. 17, 2017 | CPSH | Common Stock | Common Stock | $1.57 | Feb. 17, 2027 | 5,000 | Acquired |
| Feb. 17, 2017 | CPSH | Common Stock | Common Stock | $1.57 | Feb. 17, 2027 | 5,000 | Acquired |
| Feb. 17, 2017 | CPSH | Common Stock | Common Stock | $1.57 | Feb. 17, 2027 | 5,000 | Acquired |
| Feb. 17, 2017 | CPSH | Common Stock | Common Stock | $1.57 | Feb. 17, 2027 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $152,559 | $3,577 | · | $14,840 | · | · | $465 | $171,441 |
| 2018 | $174,250 | $26,077 | · | $28,542 | · | · | $588 | $229,457 |
| 2017 | $170,000 | $30,000 | · | $20,665 | · | · | $588 | $220,665 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.